Our findings suggest that the absence of BRCA1 or BRCA2, and thus deficient repair, leads to gene mutation and tumor initiation through the emergence of transcriptionally associated DSBs in genes categorized as tumor suppressors and proto-oncogenes. The gene discussed is BRCA2; the disease is neoplasm.